Adverum Biotech

5 followers


Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Laurent Fischer
President & CEO

Laurent Fischer

Collapse
Star Seyedkazemi
Chief Development Officer
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
John Rakow
General Counsel
Dena House
SVP, Human Resources, Organizational Development & Learning
Carla Fiankan
SVP, Regulatory Affairs
Heikki Jouttijärvi
SVP & Head, Technical Operations
Kali Stasi
SVP, Clinical Development
Bill Tan
SVP & Head, Global Clinical Operations